Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-105561
Filing Date
2024-09-11
Accepted
2024-09-11 16:50:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A itrm_proxy_letter_shareh.htm DEFA14A 32393
2 GRAPHIC img109358456_0.jpg GRAPHIC 3194
  Complete submission text file 0000950170-24-105561.txt   38109
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38503 | Film No.: 241293128
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)